141 related articles for article (PubMed ID: 2572256)
1. The management of heart failure and the scope for new therapies: what role for xamoterol?
Campbell RW
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):59S-64S. PubMed ID: 2572256
[TBL] [Abstract][Full Text] [Related]
2. Long-term studies with xamoterol in heart failure.
Waller DG
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):53S-58S. PubMed ID: 2572255
[TBL] [Abstract][Full Text] [Related]
3. Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure.
Marlow HF
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):23S-30S. PubMed ID: 2572251
[TBL] [Abstract][Full Text] [Related]
4. Focus on diastolic dysfunction: a new approach to heart failure therapy.
Pouleur H; Hanet C; Gurné O; Rousseau MF
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):41S-52S. PubMed ID: 2572254
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction.
Pouleur H; Hanet C; Rousseau MF
Eur Heart J; 1990 Apr; 11 Suppl A():33-8. PubMed ID: 1971587
[TBL] [Abstract][Full Text] [Related]
6. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
Virk SJ; Davies MK
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
[TBL] [Abstract][Full Text] [Related]
7. The pharmacology of xamoterol: a basis for modulation of the autonomic control of the heart.
Snow HM
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):3S-13S. PubMed ID: 2572252
[TBL] [Abstract][Full Text] [Related]
8. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
Rousseau MF; Cheron P; Nannan M; Vincent MF; Lavenne F; Pouleur H
Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823
[TBL] [Abstract][Full Text] [Related]
9. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
Heng MK
Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
[TBL] [Abstract][Full Text] [Related]
10. Treatment of congestive heart failure--state of the art and future trends.
Parmley WW
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):31S-39S. PubMed ID: 2572253
[TBL] [Abstract][Full Text] [Related]
11. Review of clinical experience with xamoterol. Effects on exercise capacity and symptoms in heart failure.
Marlow HF
Circulation; 1990 Feb; 81(2 Suppl):III93-8. PubMed ID: 1967561
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic hemodynamic effects of xamoterol in mild to moderate congestive heart failure.
Virk SJ; Qiang FX; Anfilogoff NH; Murray RG; Littler WA; Davies MK
Am J Cardiol; 1991 May; 67(12):48C-52C; discussion 52C-54C. PubMed ID: 1673587
[TBL] [Abstract][Full Text] [Related]
13. Selective beta-1-adrenoceptor partial agonist treatment for congestive heart failure.
Shabetai R
Cardiology; 1990; 77(5):357-66. PubMed ID: 1981492
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy of xamoterol (a beta 1-adrenoceptor partial agonist) in patients with mild to moderate heart failure.
Sørensen EV; Faergeman O; Day MA; Snow HM
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):86S-88S. PubMed ID: 2572265
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of chronic oral administration of xamoterol to patients with severe heart failure treated with ACE inhibitors.
Pouleur H; Hanet C; Rousseau MF
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):82S-83S. PubMed ID: 2572263
[TBL] [Abstract][Full Text] [Related]
16. Digoxin and xamoterol in patients with moderate chronic heart failure. A double-blind, randomized, controlled study.
Sorensen EV; Sterndorff B; Andersen MF; Faergeman O
Cardiovasc Drugs Ther; 1989 Apr; 3(2):203-9. PubMed ID: 2577283
[TBL] [Abstract][Full Text] [Related]
17. The effect of xamoterol in failing human myocardium.
Schwinger RH; Böhm M; Erdmann E
Eur Heart J; 1990 Apr; 11(4):323-7. PubMed ID: 1970536
[TBL] [Abstract][Full Text] [Related]
18. [The value of xamoterol in moderate ischemic cardiac insufficiency].
Rousseau MF; Cheron P; Vincent MF; Pouleur H; Lavenne F
Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115
[TBL] [Abstract][Full Text] [Related]
19. Xamoterol in severe congestive heart failure: long-term oral treatment, a double-blind randomised study.
Tangø M; Lyngborg K; Mehlsen J; Svendsen TL; Trap-Jensen J
Int J Cardiol; 1992 Jan; 34(1):63-8. PubMed ID: 1347763
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of digoxin and xamoterol on arrhythmias in patients with mild to moderate heart failure.
Klein W; Eber B; Rotman B
Angiology; 1992 Apr; 43(4):281-6. PubMed ID: 1348403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
